Editorial policies

The Journal of Haemophilia Practice is an international journal published in English. We accept submissions in English, sent in a Word-compatible format by email to the editorial office (mike@haemnet.com). Generally, we try to accept or reject all submissions within 6-8 weeks. Importantly, your article will never be rejected simply because it is based on too small a number of patients. We positively welcome small studies and individual case reports.

All articles will be reviewed by the managing editor and will then be sent for peer-review by one or two members of our editorial board and other experts, who will decide whether it is to be accepted or rejected. They will try to return their comments within two weeks. We ask our reviewers to offer honest and constructive feedback that can be forwarded (anonymously) to submitting authors.

Those that are accepted may be copy-edited, but your paper is more likely to be accepted if it is well structured and expressed in a clear and logical manner, and has been written in a manner consistent with our  Author Guidelines. These may differ from those of other journals – all publishers have their own preferred formats, reference styles, and so on.

In rare instances, papers may be rejected outright based on the reviewers’ comments. This is most likely to be because the standard of the writing is very poor, or the work has been published previously. More often than not, our reviewers will offer comments on how the work can be improved. Those authors who take on board and address the comments offered by our reviewers will probably find their work accepted. We ask that authors reply to reviewers’ comments in a covering email, addressing each of the reviewers’ points: suggestions do not have to be accepted but if you choose not to accept a suggestion then you should explain why in your covering email.

Open-access publication

The Journal of Haemophilia Practice is an open-access journal. All of our articles are freely available to anyone who completes the journal registration form.

Many scientific and medical journals charge a fee for access to their papers. Where the publisher is a charity or an advocacy-based organization, the money paid may support research or other good causes, which is clearly justifiable. However, the requirement to pay can limit access to published research, particularly to those in developing countries. It can also mean that publishers profit from research, which may have been publicly funded.

Open-access publishing seeks to make the fruits of research freely available to all via the Internet. Furthermore, online open-access publishing frees publishers from the constraints of paper publishing. This means that longer, more discursive papers can be accepted, which is particularly valuable as much of the work of the non-medical members of the haemophilia multi-disciplinary care team is based on qualitative experience.

Open-access publishers generally charge authors a fee to cover the editorial costs of processing a manuscript. This is a cost that many funding bodies are willing to cover.

The publisher of The Journal of Haemophilia Practice is Haemnet. Haemnet is a charity that supports education and research for people affected by bleeding disorders, and the professionals who manage them. We believe that sharing experience benefits everyone. Therefore, all of our articles are freely available to all readers to download from our website, by anyone who completes the journal registration form.

Publication fees

In most instances, we will not charge a publication fee. However, we reserve the right to do so for those papers and authors that are commercially funded.

When a paper is accepted for publication we will ask you to declare how your work was funded. We reserve the right to charge a publication-processing fee for work funded by commercial companies. This will cover editorial and production costs and will help to ensure that we can continue to support free publication of publically funded research. (Please note that as we do not routinely print articles, we do NOT make additional charges for reproduction of colour illustrations or photographs.) Further details on fees are available from the editor. Owing to fluctuations in foreign exchange rates fees may occasionally be subject to change without notice.

Copyright

Copyright on any paper published in The Journal of Haemophilia Practice is retained by the author(s) of the paper. However, we do ask all authors to sign an exclusive commercial reuse license.

As we do not have the resources to market the papers we publish we actively encourage our authors to tell others about the work they have published in our journal.

Authors may send links to colleagues, to libraries, patient groups and so on. They can also include links to the paper in presentations and post the PDF on their personal websites or on those of their (non-commercial) institutions. All we ask is that the article is not reproduced, in any media or format, or linked to for any commercial purpose (e.g. product support, etc) without the prior written consent of the editor and payment of the appropriate fee.

Authors can, of course, reuse any original figures and tables in future papers or on slide presentations without requiring permission, provided the original published work is properly referenced as the source. Please bear in mind that this might restrict the reuse of any work that has been funded by a pharmaceutical company.

Authors who wish to use photographs or illustrations in their articles are responsible for securing appropriate permissions and copyright on those illustrations.

Conflicts of interest

We ask all authors to fully disclose any conflict of interest prior to publication. This includes details of sources of funding. Disclosure of a conflict of interest will not preclude your paper from being accepted or published, but we do believe that transparency is important.

Peer review

All papers submitted to The Journal of Haemophilia Practice will be sent for peer review by at least two members of our editorial advisory board. Peer reviewers will try to return their comments within two weeks. We ask our reviewers to offer honest and constructive feedback that can be forwarded (anonymously) to submitting authors.

In rare instances, papers may be rejected outright based on the reviewers’ comments. This is most likely to be because the standard of the writing is very poor, or the work has been published previously. More often than not, our reviewers will offer comments on how the work can be improved. Those authors who take on board and address the comments offered by our reviewers will probably find their work accepted. We ask that authors reply to reviewers’ comments in a covering email, addressing each of the reviewers’ points: suggestions do not have to be accepted but if you choose not to accept a suggestion then you should explain why in your covering email.

Authors should never submit a paper to more than one journal at a time. Similarly, you should avoid plagiarism, which includes self-plagiarism. If your paper is based on previously published work, whether your own work or that of others, then please acknowledge this in the paper and reference the work. We will run all articles through widely available plagiarism software.